Showing posts with label obesity and asthma. Show all posts
Showing posts with label obesity and asthma. Show all posts

Thursday, February 06, 2014

Heavy kids exposed to air pollution have triple the risk for asthma

Photo: Arvibnd Balaraman
Obese children exposed to high levels of air pollutants were nearly three times as likely to have asthma, compared with non-obese children and lower levels of pollution exposure, report researchers at Columbia University Medical Center (CUMC).

Rates of childhood obesity and asthma have both increased dramatically in the past 30 years. The percentage of American children who are obese has increased from 7% in 1980 to 20% in 2008. Childhood asthma is up from 4% in 1980 to 10% in 2009. Rates are higher among urban minority populations.
The researchers followed 311 children in predominantly Dominican and African-American neighborhoods of New York City. They monitored indoor air in each child's home for two weeks at age 5 or 6, to measure exposure to a family of air pollutants, polycyclic aromatic hydrocarbons (PAH). The child's height and weight were measured and respiratory questionnaires were administered. In all, 20% were found to have asthma and 20% were categorized as obese based on body mass index.

The researchers found that high PAH exposure was associated with asthma only among obese children. In particular, the association was with the alkylated forms of PAH, which are emitted by vehicles and by cigarette smoke, cooking, incense, burning candles, and various other indoor air pollution sources. A two- to three-fold increase in asthma risk was seen among obese children exposed to high levels of the PAH chemicals 1-methylphenanthrene and 9-methylphenanthrene. Exposure to PAH or obesity alone did not predict asthma.

"Our results suggest that obesity may magnify the effects of these air pollutants, putting children at greater risk for having asthma," says lead author Kyung Hwa Jung, PhD, associate research scientist in the Department of Medicine at Columbia University College of Physicians and Surgeons.

-------------------------------------------------------------------------

Reduce your exposure to indoor air pollution with the flip of a switch. AllerAir air purifiers are  designed to run 24/7  and remove dust, dander, pollen, smoke and the airborne chemical pollutants and odors that most other air purifiers leave behind. Connect with us to learn more about why scientists, medical facilities, the military, heavy industry and thousands of homeowners trust their air care  to AllerAir air purifiers.

Thursday, January 10, 2013

Study offers clues to why heavy people and anorexics have higher asthma rates

A new study led by Columbia University researchers has found that leptin, a hormone that plays a key role in energy metabolism, fertility, and bone mass, also regulates airway diameter.

These findings could explain why obese people are prone to asthma and suggest that body-weight–associated-asthma may be relieved with medications which help the body mediate leptin function. The study, conducted in mice, was published in the online edition of the journal Cell Metabolism.

“Our study started with the clinical observation that both obesity and anorexia can lead to asthma,” said Gerard Karsenty MD, PhD, professor and chair of genetics and development and professor of medicine at CUMC, and lead author of the study. “This led us to suspect that there must be a signal coming from fat cells that somehow affects the lungs —directly or indirectly.” The most likely candidate was leptin, a protein made by fat cells that circulates in the bloodstream and travels to the brain.

Extensive evidence shows that obesity can cause narrowing of the airways (bronchoconstriction). When obesity develops in people with asthma, it exacerbates the breathing disorder and hampers its treatment through mechanisms that are poorly understood. The current study was designed to elucidate the genetic and molecular bases of the relationships among obesity, airway diameter, and lung function.

Through mouse studies, the researchers showed that abnormally low or high body weight and fat mass results in bronchoconstriction and diminished lung function. Next, they showed that leptin increases airway diameter independently of, and at a lower threshold than, its regulation of appetite.

Leptin affects the airways by decreasing the activity of the parasympathetic nervous system, a branch of the autonomic nervous system not usually associated with leptin. The researchers also showed that regulation of airway diameter occurs regardless of local inflammation in the bronchi.

The researchers conducted two subsequent experiments to determine if these findings might have bearing on asthma therapy. In one, they took obese, asthmatic mice and administered a substance that increases lung inflammation. When they infused leptin in the brain of these mice for four days, “There was no effect on inflammation, but airway diameter and lung functions were normal,” said Dr. Karsenty. “This showed that, at least in the mouse, you can cure obesity-related asthma without affecting inflammation.” In the second experiment, the researchers treated obese, asthmatic mice with drugs that decrease parasympathetic tone, or rate of neuronal firing. Again, the asthma abated after several days.

“The therapeutic implication is that it may be possible to correct asthma in obese people with drugs that inhibit parasympathetic signaling—and thereby inhibit leptin deficiency-related brain signaling,” said Dr. Karsenty. Such drugs are already available. One is tiotropium bromide, which is used primarily for the treatment of chronic obstructive pulmonary disease. Clinical trials are needed before this or a more active and selective drug can be recommended for the treatment of body weight–associated asthma, Dr. Karsenty added.